VOYA INVESTMENT MANAGEMENT LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$42,170,000
+30.5%
910,206
-31.3%
0.09%
+24.7%
Q1 2019$32,308,000
+23.1%
1,325,190
-28.1%
0.07%
+12.3%
Q4 2018$26,251,000
-25.0%
1,842,171
-20.0%
0.06%
-9.7%
Q3 2018$34,982,000
+4.3%
2,301,455
+15.1%
0.07%
+1.4%
Q2 2018$33,551,000
+89.3%
1,999,490
+84.1%
0.07%
+86.8%
Q1 2018$17,723,000
+1492.4%
1,086,011
+1148.9%
0.04%
+1800.0%
Q4 2017$1,113,000
+12.9%
86,956
+8.5%
0.00%0.0%
Q3 2017$986,000
+46.9%
80,1750.0%0.00%0.0%
Q2 2017$671,000
+12.8%
80,175
+20.4%
0.00%
+100.0%
Q1 2017$595,000
+7.4%
66,573
+5.5%
0.00%0.0%
Q4 2016$554,000
+30.0%
63,0790.0%0.00%0.0%
Q3 2016$426,000
+89.3%
63,0790.0%0.00%0.0%
Q2 2016$225,000
+21.0%
63,0790.0%0.00%
Q1 2016$186,000
-30.1%
63,0790.0%0.00%
-100.0%
Q4 2015$266,000
-7.6%
63,0790.0%0.00%0.0%
Q3 2015$288,000
-45.6%
63,079
-14.1%
0.00%0.0%
Q2 2015$529,000
-7.2%
73,398
-5.1%
0.00%0.0%
Q1 2015$570,000
+55.7%
77,3300.0%0.00%0.0%
Q4 2014$366,000
+32.6%
77,3300.0%0.00%0.0%
Q3 2014$276,000
-21.8%
77,3300.0%0.00%0.0%
Q2 2014$353,000
-2.8%
77,3300.0%0.00%0.0%
Q1 2014$363,000
-6.2%
77,3300.0%0.00%0.0%
Q4 2013$387,000
-19.5%
77,3300.0%0.00%0.0%
Q3 2013$481,000
+37.0%
77,3300.0%0.00%0.0%
Q2 2013$351,00077,3300.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 15,978,580$268,121,0009.11%
BVF INC/IL 4,672,195$78,399,0007.65%
First Light Asset Management, LLC 2,391,575$40,131,0006.25%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 694,500$11,647,0004.47%
Copernicus Capital Management, LLC 286,797$4,812,0003.49%
PACIFIC VIEW ASSET MANAGEMENT, LLC 225,511$3,784,0003.00%
SECTORAL ASSET MANAGEMENT INC 1,566,477$26,285,0002.94%
X-Square Capital, LLC 173,802$2,917,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 2,618,654$43,941,0001.48%
Birchview Capital, LP 128,000$2,148,0001.46%
View complete list of ARRAY BIOPHARMA INC shareholders